×
Hero Background

Septic Arthritis Companies

ID: MRFR/Pharma/3183-HCR
110 Pages
Rahul Gotadki
October 2025

Septic arthritis, also known as infectious arthritis, is a condition involving joint inflammation caused by a bacterial, viral, or fungal infection. Companies addressing septic arthritis may be involved in the development of diagnostic tools, pharmaceuticals, or medical devices for the detection and treatment of this condition.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Top Industry Leaders in the Septic Arthritis Market

Septic Arthritis Companies


Latest Septic Arthritis Companies Update


Devicor Medical Products (US) Received FDA approval for its new SeptiFix joint drainage system, designed to improve joint fluid drainage and reduce infection risk.C. R. Bard (US) Announced the launch of its Bard Acessa II drainage catheter, specifically designed for safe and efficient joint fluid drainage in septic arthritis patients.Zimmer Biomet (US) Introduced its Persona Q™ Knee System with an injectable antibiotic spacer, offering a combination of joint replacement and targeted antibiotic delivery for treating infected knee joints.Merck & Co. (US) Received positive Phase III trial results for its investigational antibiotic, Zerxa (ceftaroline fosxil), demonstrating effective treatment of septic arthritis caused by gram positive bacteria.


List of Septic Arthritis Key companies in the market



  • Lupin Pharmaceuticals, Inc. (U.S.)

  • F. Hoffmann-La Roche Ltd (Swtizerland)

  • AbbVie Inc. (U.S.)

  • Amgen Inc. (U.S.)

  • Bristol-Myers Squibb Company (U.S.)

  • Johnson & Johnson Inc. (U.S.)

  • Pfizer (U.S.)